
Radioligand therapy and drugs like Lutathera® and Pluvicto® from Novartis are “game changers” for treating certain types of cancer. Read more about the benefits of these treatments and their complicated journey from reactors to patients here.

Radioligand therapy is featured on CNBC.com
Radioligand therapy and drugs like Lutathera® and Pluvicto® from Novartis are “game changers” for treating certain types of cancer. Read more about the benefits of these treatments and their complicated journey from reactors to patients here.